Oracle and Wipro Formed Healthcare Cloud Partnership
The two companies have teamed up to provide cloud-based pharmacovigilance services for life sciences organizations.
Updated on Sept. 22, 2026 in Healthcare
Live Poll
Do you trust that outsourcing essential safety operations to larger technology partners improves product reliability?
Oracle Life Sciences and Wipro have announced a new partnership to offer cloud-based pharmacovigilance services globally. The collaboration utilizes the Oracle Argus platform to manage drug safety data and regulatory reporting workflows.
Why it matters
The partnership aims to help life sciences firms scale their drug safety operations more efficiently. By moving to a cloud-based service model, organizations can avoid the burden of maintaining on-premise infrastructure.
The partnership integrates Wipro services with the Oracle Life Sciences Argus Business Process Services platform. This model replaces traditional on-premise safety systems with scalable cloud environments.
The players
Oracle Life Sciences
This division of the technology giant provides software solutions specifically tailored for clinical research and drug safety management.
Wipro
Wipro is a major multinational corporation that provides information technology, consulting, and business process services to global clients.
The details
Wipro will utilize preconfigured environments of the Oracle Argus platform to streamline case processing, regulatory reporting, and post-marketing surveillance. This approach is designed to shorten implementation timelines for life sciences customers significantly.
Timeline
September 22, 2026: Oracle and Wipro announced their new global partnership.
Market Landscape
The collaboration reflects the broader industry move toward managed cloud infrastructure in the life sciences sector. It positions the companies against other providers of safety data management by emphasizing faster implementation through preconfigured workflows.
Life sciences organizations adopting this service can expect streamlined safety reporting and reduced infrastructure management requirements. Clients will likely see shorter project implementation windows due to the use of preconfigured digital environments.
The takeaway
Outsourcing pharmacovigilance to specialized cloud providers allows life sciences companies to focus resources on research rather than IT maintenance. This shift enables faster regulatory compliance and more responsive drug safety monitoring across global markets.
Further reading
For more on evolving standards in medical technology, explore the latest updates in Healthcare.
Live Poll
Do you trust that outsourcing essential safety operations to larger technology partners improves product reliability?
